UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The role of circulating mesenchymal progenitor cells (fibrocytes) in the pathogenesis of pulmonary fibrosis

Journal of leukocyte biology, 2009-11, Vol.86 (5), p.1111-1118

2009

Volltextzugriff (PDF)

Fibrocyte CXCR4 regulation as a therapeutic target in pulmonary fibrosis

The international journal of biochemistry & cell biology, 2009-08, Vol.41 (8-9), p.1708-1718

2009

Volltextzugriff (PDF)

Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis

The Journal of clinical investigation, 2004-08, Vol.114 (3), p.438-446

2004

Volltextzugriff (PDF)

Number, activation, and differentiation of circulating fibrocytes correlate with asthma severity

Journal of allergy and clinical immunology, 2016-03, Vol.137 (3), p.750-757.e3

2016

Volltextzugriff (PDF)

Circulating peripheral blood fibrocytes in human fibrotic interstitial lung disease

Biochemical and biophysical research communications, 2007-02, Vol.353 (1), p.104-108

2007

Volltextzugriff (PDF)

Neutrophils Mediate Maturation and Efflux of Lung Dendritic Cells in Response to Aspergillus fumigatus Germ Tubes

Infection and Immunity, 2012-05, Vol.80 (5), p.1759-1765

2012

Volltextzugriff (PDF)

Angiostatic and chemotactic activities of the CXC chemokine CXCL4L1 (platelet factor-4 variant) are mediated by CXCR3

Blood, 2011-01, Vol.117 (2), p.480-488

2011

Volltextzugriff (PDF)

CXC chemokines in angiogenesis

Journal of leukocyte biology, 2000-07, Vol.68 (1), p.1-8

2000

Volltextzugriff (PDF)

Circulating fibrocytes traffic to the lung in murine acute lung injury and predict outcomes in human acute respiratory distress syndrome: a pilot study

Molecular medicine (Cambridge, Mass.), 2020-05, Vol.26 (1), p.52-52, Article 52

2020

Volltextzugriff (PDF)

The Stromal Derived Factor-1/CXCL12-CXC Chemokine Receptor 4 Biological Axis in Non-Small Cell Lung Cancer Metastases

American journal of respiratory and critical care medicine, 2003-06, Vol.167 (12), p.1676-1686

2003

Volltextzugriff (PDF)

CXC‐chemokine/CXCR2 biological axis promotes angiogenesis in vitro and in vivo in pancreatic cancer

International journal of cancer, 2009-09, Vol.125 (5), p.1027-1037

2009

Volltextzugriff (PDF)

Stromal derived factor-1 (SDF-1/CXCL12) and CXCR4 in renal cell carcinoma metastasis

Molecular cancer, 2006-11, Vol.5 (1), p.56-56, Article 56

2006

Volltextzugriff (PDF)

Critical role for CXCR2 and CXCR2 ligands during the pathogenesis of ventilator-induced lung injury

The Journal of clinical investigation, 2002-12, Vol.110 (11), p.1703-1716

2002

Volltextzugriff (PDF)

M-CSF Mediates Host Defense during Bacterial Pneumonia by Promoting the Survival of Lung and Liver Mononuclear Phagocytes

The Journal of immunology (1950), 2016-06, Vol.196 (12), p.5047-5055

2016

Volltextzugriff (PDF)

Plasma CXCL12 Levels as a Predictor of Future Stroke

Stroke (1970), 2012-12, Vol.43 (12), p.3382-3386

2012

Volltextzugriff (PDF)

Circulating fibrocytes as biomarker of prognosis in Hermansky-Pudlak syndrome

American journal of respiratory and critical care medicine, 2014-12, Vol.190 (12), p.1395-1401

2014

Volltextzugriff (PDF)

Sirolimus suppresses circulating fibrocytes in idiopathic pulmonary fibrosis in a randomized controlled crossover trial

JCI insight, 2023-04, Vol.8 (8)

2023

Volltextzugriff (PDF)

High expression of ligands for chemokine receptor CXCR2 in alveolar epithelial neoplasia induced by oncogenic kras

Cancer research (Chicago, Ill.), 2006-04, Vol.66 (8), p.4198-4207

2006

Volltextzugriff (PDF)

The CXC Chemokine Receptor 2, CXCR2, Is the Putative Receptor for ELR+ CXC Chemokine-Induced Angiogenic Activity

The Journal of immunology (1950), 2000-11, Vol.165 (9), p.5269-5277

2000

Volltextzugriff (PDF)

Cutting Edge: IFN-Inducible ELR- CXC Chemokines Display Defensin-Like Antimicrobial Activity

The Journal of immunology (1950), 2001-07, Vol.167 (2), p.623-627

2001

Volltextzugriff (PDF)

Circulating fibrocytes as prognostic biomarkers of autoimmune interstitial lung disease

ERJ open research, 2020-10, Vol.6 (4), p.481

2020

Volltextzugriff (PDF)

BRAK/CXCL14 is a potent inhibitor of angiogenesis and a chemotactic factor for immature dendritic cells

Cancer research (Chicago, Ill.), 2004-11, Vol.64 (22), p.8262-8270

2004

Volltextzugriff (PDF)

The Role of CXCR2/CXCR2 Ligand Biological Axis in Renal Cell Carcinoma

The Journal of immunology (1950), 2005-10, Vol.175 (8), p.5351-5357

2005

Volltextzugriff (PDF)

Platelets Release CXCL4L1, a Nonallelic Variant of the Chemokine Platelet Factor-4/CXCL4 and Potent Inhibitor of Angiogenesis

Circulation Research, 2004-10, Vol.95 (9), p.855-857

2004

Volltextzugriff (PDF)

Platelet factor-4 variant chemokine CXCL4L1 inhibits melanoma and lung carcinoma growth and metastasis by preventing angiogenesis

Cancer research (Chicago, Ill.), 2007-06, Vol.67 (12), p.5940-5948

2007

Volltextzugriff (PDF)

1 – 25 von 212

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(204)
Mit Volltextzugriff
(183)

Publikationsform

Sprache

Englisch
(212)

Erscheinungsjahr

n.n

Thema

Science & Technology
(157)
Life Sciences & Biomedicine
(153)
Humans
(112)
Animals
(110)
Mice
(79)
Biological And Medical Sciences
(70)
Immunology
(58)
Female
(53)
Medical Sciences
(50)
Male
(39)
Rats
(30)
Chemokines
(27)
Molecular Sequence Data
(23)
Respiratory System
(23)
Fundamental And Applied Biological Sciences. Psychology
(22)
Medicine, Research & Experimental
(22)
Research & Experimental Medicine
(22)
Cell Biology
(21)
Cells, Cultured
(21)
Chemokines, Cxc - Physiology
(21)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The role of circulating mesenchymal progenitor cells (fibrocytes) in the pathogenesis of pulmonary fibrosis

Fibrocyte CXCR4 regulation as a therapeutic target in pulmonary fibrosis

Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis

Number, activation, and differentiation of circulating fibrocytes correlate with asthma severity

Circulating peripheral blood fibrocytes in human fibrotic interstitial lung disease

Neutrophils Mediate Maturation and Efflux of Lung Dendritic Cells in Response to Aspergillus fumigatus Germ Tubes

Angiostatic and chemotactic activities of the CXC chemokine CXCL4L1 (platelet factor-4 variant) are mediated by CXCR3

CXC chemokines in angiogenesis

Circulating fibrocytes traffic to the lung in murine acute lung injury and predict outcomes in human acute respiratory distress syndrome: a pilot study

The Stromal Derived Factor-1/CXCL12-CXC Chemokine Receptor 4 Biological Axis in Non-Small Cell Lung Cancer Metastases

CXC‐chemokine/CXCR2 biological axis promotes angiogenesis in vitro and in vivo in pancreatic cancer

Stromal derived factor-1 (SDF-1/CXCL12) and CXCR4 in renal cell carcinoma metastasis

Critical role for CXCR2 and CXCR2 ligands during the pathogenesis of ventilator-induced lung injury

M-CSF Mediates Host Defense during Bacterial Pneumonia by Promoting the Survival of Lung and Liver Mononuclear Phagocytes

Plasma CXCL12 Levels as a Predictor of Future Stroke

Circulating fibrocytes as biomarker of prognosis in Hermansky-Pudlak syndrome

Sirolimus suppresses circulating fibrocytes in idiopathic pulmonary fibrosis in a randomized controlled crossover trial

High expression of ligands for chemokine receptor CXCR2 in alveolar epithelial neoplasia induced by oncogenic kras

The CXC Chemokine Receptor 2, CXCR2, Is the Putative Receptor for ELR+ CXC Chemokine-Induced Angiogenic Activity

Cutting Edge: IFN-Inducible ELR- CXC Chemokines Display Defensin-Like Antimicrobial Activity

Circulating fibrocytes as prognostic biomarkers of autoimmune interstitial lung disease

BRAK/CXCL14 is a potent inhibitor of angiogenesis and a chemotactic factor for immature dendritic cells

The Role of CXCR2/CXCR2 Ligand Biological Axis in Renal Cell Carcinoma

Platelets Release CXCL4L1, a Nonallelic Variant of the Chemokine Platelet Factor-4/CXCL4 and Potent Inhibitor of Angiogenesis

Platelet factor-4 variant chemokine CXCL4L1 inhibits melanoma and lung carcinoma growth and metastasis by preventing angiogenesis

Suchergebnisse filtern